Caris Life Sciences, Inc. (CAI) experienced a pre-market plunge of 9.83% on Friday, following the release of its quarterly earnings results.

Despite reporting breakeven earnings per share for the quarter, which beat analyst expectations of a 2-cent loss, and revenue of $216.17 million that exceeded forecasts, investor sentiment turned negative. The company reported a quarterly loss of $510 thousand, and market attention has been drawn to significant downward revisions in analyst earnings estimates over the past three months, which fell by approximately 146.6%.

The sharp decline in pre-market trading suggests that investors are focusing on the underlying loss and the trend of reduced expectations, even as the company surpassed the lowered consensus figures for the latest quarter.